Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00898781 · ClinicalTrials.gov registry record
Study of Circulating Cancer Cells in Patients With Metastatic Breast, Ovarian, Colon, or Pancreatic Cancer
A clinical trial, sponsored by Mayo Clinic.
- Terminated
- Registry status
- 80
- Enrollment target
NCT00898781 is a clinical trial that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 80 participants.
The verdict
NCT00898781 was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- 80 participants
- Enrollment target
Study Summary
RATIONALE: Counting the number of circulating cancer cells in samples of blood from patients with metastatic cancer may help doctors find out how much the cancer has spread. PURPOSE: This research study is looking at the number of circulating cancer cells in patients with metastatic breast cancer, ovarian cancer, colon cancer, or pancreatic cancer.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2007-11 |
| Est. Completion | 2010-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00898781
The ClinicalTrials.gov registry entry for NCT00898781 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00898781 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00898781 about?
NCT00898781 is a clinical study titled "Study of Circulating Cancer Cells in Patients With Metastatic Breast, Ovarian, Colon, or Pancreatic Cancer". RATIONALE: Counting the number of circulating cancer cells in samples of blood from patients with metastatic cancer may help doctors find out how much the cancer has spread. PURPOSE: This research study is looking at the number of circulating cancer cells in patients with metastatic breast cancer, ...
What is the current status of trial NCT00898781?
This trial is currently terminated. The enrollment target is 80 participants. The study started on 2007-11. Estimated completion is 2010-04.
Who is sponsoring clinical trial NCT00898781?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.